01029nam 2200325 450 99657498020331620230417054254.01-66547-332-0(IEEE)9925204(CKB)25219799900041(NjHacI)9925219799900041(EXLCZ)992521979990004120230417d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrier2022 Forum on Specification & Design Languages (FDL) /Institute of Electrical and Electronics Engineers[Place of publication not identified] :Institute of Electrical and Electronics Engineers,2022.1 online resourceLanguages, ArtificialLanguages, Artificial.499.99NjHacINjHaclPROCEEDING9965749802033162022 Forum on Specification & Design Languages (FDL)3881739UNISA04183nam 2200577 a 450 991096754470332120251116181713.01-61324-739-7(CKB)2550000001042175(EBL)3019568(SSID)ssj0000852593(PQKBManifestationID)12368641(PQKBTitleCode)TC0000852593(PQKBWorkID)10853103(PQKB)10790637(MiAaPQ)EBC3019568(Au-PeEL)EBL3019568(CaPaEBR)ebr10671133(OCoLC)830627793(BIP)32691832(EXLCZ)99255000000104217520101014d2011 uy 0engur|n|---|||||txtccrE. coli infections causes, treatment and prevention /Morgan C. Rogers and Nancy D. Peterson, editors1st ed.Hauppauge, N.Y. Nova Science Publishers Inc.20111 online resource (270 p.)Bacteriology research developmentsDescription based upon print version of record.1-61122-859-X Includes bibliographical references and index.Uropathogenic escherichia coli : the pre-eminent urinary tract infection pathogen / David W. Hilbert, Women's Health Research Center, Medical Diagnostic Laboratories, Hamilton, New Jersey, USA -- E. coli Infections in Urology : Causes, Treatment and Prevention / Chelsea N. Elwood, Peter Cadieux, Dirk Lange, The Stone Centre at Vancouver General Hospital, University of British Columbia (UBC), Vancouver, British Columbia, Canada, and others -- Aptamer-Based Detection and Therapeutics to Prevent and Treat E. coli Infections / John G. Bruno, Maria P. Carrillo, Taylor Phillips, Alissa Savage, Joseph R. Koke, Operational Technologies Corporation, San Antonio, Texas, USA, and others -- Lactoferrin : A Novel Natural Host Defense Protein against Escherichia coli Infection / Chih-Ching Yen, Hsiao-Ling Chen, Chuan-Mu Chen, Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan, and others --Perinatal Antibiotic Use and Antimicrobial Resistance : Examining Escherichia coli as a Model / Nevio Cimolai, Program of Microbiology, Virology, and Infection Control, Children's and Women's Health Centre of British Columbia, Vancouver, British Columbia, Canada, and others -- Implication of Enterotoxigenic Escherichia coli Pathogenicity from the Human Perspective / Iram Liaqat, University of Western Australia -- Prevention of E. coli Infections using Organic Acids / Eva Skrivanová, Milan Marounek, Institute of Animal Science, Department of Physiology of Nutrition and Quality of Animal Products, Prátelství, Prague, Czech Republic -- Current Status on the Etiology, Epidemiology, Food Safety Implications and Control Measures in Escherichia coli 0157:H7 Infections / G. Normanno, Department of Health and Animal Welfare, Faculty of Veterinary Medicine, Valenzano (Ba), Italy -- Maillard Reaction and Spontaneous Mutagenesis in Escherichia coli / Roumyana Mironova, Yordan Handzhiyski, Toshimitsu Niwa, Alfredo Berzal-Herranz, Kirill A. Datsenko, Barry L. Wanner, Ivan Ivanov, Department of Gene Regulations, Institute of Molecular Biology, Bulgarian Academy of Sciences, Sofia, Bulgaria, and others.Presents research in the study of E coli infections, including urinary tract infections caused by E coli; aptamer-based detection and therapeutics to prevent and treat E coli infections; Lactoferrin as a novel natural host defence protein; enterotoxigenic escherichia coli colonisation factors; and, the prevention of E coli using organic acids.Bacteriology research developments series.Escherichia coli infectionsEscherichia coli infections.579.3/42Rogers Morgan C1863498Peterson Nancy D1863499MiAaPQMiAaPQMiAaPQBOOK9910967544703321E. coli infections4470148UNINA